TOP STORIES

• BUSINESS Gilead Shelves Sunlenca’s PrEP Program in Japan as Coverage Issue Weighs
  April 17, 2025

• BUSINESS Gilead Japan Revving Up Oncology Drive with Trodelvy, CAR-T as Legs of Growth
  April 17, 2025

• REGULATORY MHLW to Revise Patent Linkage Scheme in FY2025, Create Expert Committee
  April 16, 2025

• BUSINESS Marubeni Sees Drug Biz Opportunities in Global Markets with Supply-Demand Gaps
  April 16, 2025

• BUSINESS AstraZeneca Eyes 40 Approvals by 2030 in Japan, Driven by New Modalities
  April 15, 2025

• BUSINESS Servier Poised to Double Japan Workforce over Next 3 Years: CEO, Local Chief
  April 14, 2025

• REGULATORY Japan Govt Ends Subsidies for COVID Vaccinations from FY2025
  April 14, 2025

• BUSINESS Japan Biotechs to Be Hit Hard by TSE Growth Market Reform, 26 Firms Fail to Reach Proposed Threshold
  April 11, 2025

• REGULATORY Nippon Ishin Co-Leader Shows Understanding of Off-Year Price Revisions
  April 11, 2025

• REGULATORY Bill to Nix Off-Year Scheme Politicized, Could Clear Lower House with Ishin Support
  April 10, 2025

• REGULATORY Amgen’s Imdelltra, CSL’s Andembry to Join NHI Price List on April 16
  April 10, 2025

• ORGANIZATION No. 1 Priority of Public-Private Council Must Be Drug Pricing: PhRMA Japan Chair
  April 9, 2025

• REGULATORY Public-Private Council Will Meet This Summer: Japan PM
  April 8, 2025

• REGULATORY Diet Begins Deliberations on Amendment of PMD Act, Bill to Repeal Off-Year Scheme
  April 7, 2025

• BUSINESS Jump in New Grad Hires Seen with Drug Makers in Japan: 2025 Poll
  April 4, 2025

• REGULATORY Japan Mulls Amendment of GCP Ordinance, Making Single IRBs a Rule
  April 3, 2025

• REGULATORY Japan Picks 14 “Loss” Products as Drugs with Highest Priority for Development
  April 2, 2025

• ORGANIZATION JPMA Renews Call for Social Security Not Reliant on Drug Price Cuts: FY2025 Policy
  April 2, 2025

• COMMENTARY How Will Japan Deal with Expected Cost Spike with Japan-Made Antibiotic APIs?
  April 1, 2025

• REGULATORY Japan Jittery over Mass Layoffs at FDA, though HHS Says Reviewers Won’t Be Affected
  March 31, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• …
• Next ›
• 最終 »